Admission Date:  [**2161-1-16**]              Discharge Date:   [**2161-1-23**]  Date of Birth:  [**2104-1-10**]             Sex:   F  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 2181**] Chief Complaint: shortness of breath  Major Surgical or Invasive Procedure: CPAP  History of Present Illness: 56F with adult onset asthma ([**2151**], status post 3 prior intubations with prolonged wean) and chronic obstructive pulmonary disease (COPD, 2L home O2, no home steroids), obstructive sleep apnea, admitted to ICU [**2161-1-16**] for COPD exacerbation.
This is her second hospitalization this year for respiratory distress and she requires home oxygen (2L per nasal cannula) but not daily steroid therapy.
She uses her albuterol inhaler or nebulizer therapy daily and denies medical non-compliance.
In the ED, the patient was treated with combivent nebs, solumedrol 125 mg IV x 1, heliox  and eventually placed on non-invasive positive pressure ventilation (NIPPV).
Over the day prior to transfer to the medicine floor on [**1-21**], the patient tolerated weaning from NIPPV/heliox to NC, spaced out nebs every 6hrs, changed from IV to oral steroid therapy, and tolerated an oral diet.
Past Medical History: Adult onset asthma ([**2151**], s/p 3 prior intubations and prolonged weans), chronic obstructive pulmonary disease (home O2 2L NC, FEV1 1.02 [**9-/2160**]), obstructive sleep apnea (CPAP at home 14), gastroesophageal reflux disease, hypertension, diabetes, diastolic congestive heart failure per transthoracic echocardiogram [**2157**] (E/A 1.67), eczema, seasonal allergies   Social History: Denies alcohol and illicit drug use.
Family History: asthma, diabetes  Physical Exam: T 97.8  BP 113/73  P 82  R 17  Sat 99% 5L NC Gen: pleasant obese female, sitting in chair comfortably, NAD HEENT: PERRL, EOMI, OP clear with MMM, no sinus tenderness Neck: supple, NT, no LAD, no JVD Pulm: prolonged exp phase, fair air movement, scattered exp wheezes throughout, no rales CV: RRR, S1S2, no m/r/g Abd: s/nt/obese +BS Ext: 1+ edema nonpitting, +2DP pulses bilaterally Neuro: AOx3, CN2-12 intact, no focal weakness or sensory deficit, no dysarthria   Pertinent Results: LABS ED/ICU COURSE CBC: [**2161-1-21**] 05:01AM BLOOD WBC-9.7 RBC-3.89* Hgb-12.4 Hct-38.5 MCV-99* MCH-31.8 MCHC-32.2 RDW-13.2 Plt Ct-289 [**2161-1-20**] 03:58AM BLOOD WBC-8.8 RBC-3.64* Hgb-11.6* Hct-36.3 MCV-100* MCH-32.0 MCHC-32.1 RDW-13.2 Plt Ct-261 [**2161-1-18**] 03:58AM BLOOD WBC-11.9*# RBC-3.56* Hgb-11.8* Hct-35.4* MCV-100* MCH-33.3* MCHC-33.4 RDW-12.9 Plt Ct-283 [**2161-1-17**] 04:30AM BLOOD WBC-6.3 RBC-3.88* Hgb-12.0 Hct-37.6 MCV-97 MCH-31.0 MCHC-32.0 RDW-13.2 Plt Ct-274 [**2161-1-16**] 02:30AM BLOOD WBC-4.9# RBC-3.96* Hgb-13.0 Hct-38.9 MCV-98 MCH-32.8* MCHC-33.4 RDW-12.9 Plt Ct-276 [**2161-1-16**] 02:30AM BLOOD Neuts-43.8* Lymphs-40.9 Monos-5.1 Eos-9.6* Baso-0.6 CHEM/LYTES: [**2161-1-21**] 05:01AM BLOOD Glucose-130* UreaN-22* Creat-0.7 Na-138 K-4.6 Cl-102 HCO3-29 AnGap-12 [**2161-1-20**] 03:58AM BLOOD Glucose-163* UreaN-23* Creat-0.6 Na-143 K-4.1 Cl-98 HCO3-42* AnGap-7* [**2161-1-19**] 02:51AM BLOOD Glucose-139* UreaN-20 Creat-0.6 Na-143 K-3.9 Cl-100 HCO3-39* AnGap-8 [**2161-1-17**] 04:30AM BLOOD Glucose-131* UreaN-17 Creat-0.7 Na-142 K-4.2 Cl-102 HCO3-37* AnGap-7* [**2161-1-16**] 02:30AM BLOOD Glucose-136* UreaN-10 Creat-0.7 Na-142 K-3.6 Cl-99 HCO3-37* AnGap-10 [**2161-1-21**] 05:01AM BLOOD Calcium-9.0 Phos-4.4 Mg-2.3 [**2161-1-20**] 04:50PM BLOOD Mg-2.6 [**2161-1-19**] 04:12PM BLOOD Cholest-208* [**2161-1-19**] 02:51AM BLOOD Calcium-8.9 Phos-2.9 Mg-2.7* [**2161-1-18**] 03:58AM BLOOD Calcium-8.5 Phos-4.1 Mg-2.6 LIPIDS: [**2161-1-19**] 04:12PM BLOOD Triglyc-105 HDL-74 CHOL/HD-2.8 LDLcalc-113 ABG: [**2161-1-21**] 09:27AM BLOOD Type-ART Temp-37.0 pO2-80* pCO2-50* pH-7.35 29 [**2161-1-16**] 10:23AM BLOOD Type-ART pO2-56* pCO2-64* pH-7.34* Lactate-2.4* MICRO: [**2161-1-19**] 2:54 pm SPUTUM     Site: EXPECTORATED GRAM STAIN (Final [**2161-1-19**]): <10 PMNs and >10 epithelial cells/100X field.
GRAM STAIN OF THIS SPECIMEN INDICATES CONTAMINATION WITHOROPHARYNGEAL SECRETIONS AND INVALIDATES RESULTS.
Slight prominence of the right cardiphrenic angle probably represents a combination of lung markings and a prominent fat pad.
Her respiratory status improved and she was transferred [**2161-1-21**] to the medicine floor for further management.
Presentation with respiratory distress- The patient has long history of prior tobacco abuse and developed a COPD flare while on home oxygen with an unknown trigger.
She likely has a component of carbon dioxide retention considering her increased carbon dioxide on arterial blood gases.
Her respiratory status improved during her ICU course which included solumedrol 125 tid.
Medications included [**Month/Day/Year 8895**], flovent, albuterol INH, atrovent INH, atrovent nebs q6H, and albuterol nebs.
Ambulatory and resting oxygen saturations were appropriate at approximately 95-98% at her home regimen of 2L nasal cannula oxygen supplementation.
She will finish a 2 week taper course of oral steroids and 2 week course of oral levoquin that will end [**2161-1-30**].
Her home regimen is 14mm per home regimen.
Diastolic CHF: The patient's CXR was without significant effusions and did not improve after lasix 20mg IV given in the ED.
Her home regimen including lisinopril 40mg daily and aspirin was continued.
Diabetes - Her diabetes was well controlled on RISS and NPH 70/30 twice daily.
GERD - Protonix was continued.
The patient was discharged in good condition eating a diabetic/cardiac healthy diet and ambulating well.
Medications on Admission: salmeterol 50mcg [**Hospital1 **] ipratroprium inh q6hrs albuterol inh q4hrs [**Hospital1 8895**] 10mg daily flovent 440mcg inh [**Hospital1 **] fluticasone 110mcg 4p inh [**Hospital1 **] protonix 40mg daily lisinopril 40mg daily RISS insulin 70/30 30U QAM and 18U QPM furosemide 40mg daily aspirin 81mg daily   Discharge Medications: 1.
Levofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours) for 7 days.
Montelukast Sodium 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Fluticasone Propionate 110 mcg/Actuation Aerosol Sig: Four (4) Puff Inhalation [**Hospital1 **] (2 times a day).
Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.)
Lisinopril 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Fluticasone Propionate 50 mcg/Actuation Aerosol, Spray Sig: Four (4)  Nasal twice a day.
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Albuterol Sulfate 0.083 % Solution Sig: One (1)  Inhalation Q4-6H (every 4 to 6 hours) as needed for shortness of breath or wheezing.
Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation every 4-6 hours as needed for shortness of breath or wheezing.
Ipratropium Bromide 18 mcg/Actuation Aerosol Sig: One (1) Puff Inhalation every six (6) hours.
Albuterol 90 mcg/Actuation Aerosol Sig: One (1) Puff Inhalation every four (4) hours as needed.
Dextromethorphan-Guaifenesin 10-100 mg/5 mL Syrup Sig: [**4-21**] MLs PO Q6H (every 6 hours) as needed.
Insulin 70/30 70-30 unit/mL Suspension Sig: Thirty (30) units Subcutaneous QAM.
Insulin 70/30 70-30 unit/mL Suspension Sig: Eighteen (18) units Subcutaneous QPM.
Prednisone 20 mg Tablet Sig: Three (3) Tablet PO once a day for 2 days: take [**2161-1-24**] and [**2161-1-25**].
Prednisone 20 mg Tablet Sig: Two (2) Tablet PO once a day for 4 days: take [**2161-1-26**] through [**2161-1-29**].
Prednisone 5 mg Tablet Sig: One (1) Tablet PO once a day for 4 days: take [**2161-2-3**] through [**2161-2-6**].
Prednisone 5 mg Tablet Sig: Two (2) Tablet PO once a day for 4 days: take [**2161-1-30**] through [**2161-2-2**] .
Insulin Regular Human 100 unit/mL Cartridge Sig: One (1) Injection four times a day as needed for elevated blood glucose: as directed per sliding scale.
Disp:*1 * Refills:*2*   Discharge Disposition: Home  Discharge Diagnosis: Primary: Adult onset asthma chronic obstructive pulmonary disease obstructive sleep apnea Secondary: gastroesophageal reflux disease, hypertension, diabetes, diastolic congestive heart failure, eczema, seasonal allergies   Discharge Condition: good, in usual state of health, breathing at baseline comfort level and oxygen saturation without wheezing without distress, ambulating with good oxygen saturation, eating oral diet  Discharge Instructions: Please monitor your respiratory status.
Please take all medications as prescribed and use your CPAP machine at home.
Finish all of your antibiotic (levofloxacin).
Finish your prescription for prednisone with a dose that will be tapered slowly over the next few weeks.
